SecBot SecBot
SECBOTREPLAY Home › Report › WST

WST · Analysis based on filing metadata only, document content was unavailable

WEST PHARMACEUTICAL SERVICES INC · DEFA14A filed Mar 12, 2026 at 08:32 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Mar 12, 2026 at 08:32 ET

Analysis based on filing metadata only, document content was unavailable

  • Filing is a DEFA14A (Definitive Additional Materials) for West Pharmaceutical Services, Inc.
  • It is a proxy statement for the 2026 Annual Meeting.
  • The meeting will be held virtually on May 4, 2026.
  • Proposals include the election of 11 directors, an advisory vote on executive compensation, ratification of the independent auditor, and a shareholder proposal on an independent board chair.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access